Extrarenal/JJ
receptor-effector-mechanisms/NNS
for/IN
aldosterone/NN
:/:
the/DT
sequence/NN
of/IN
effects/NNS
on/IN
the/DT
cellular/JJ
electrolyte/NN
transport/NN
in/IN
human/JJ
lymphocytes/NNS
and/CC
their/PRP$
implications/NNS
for/IN
disorders/NNS
of/IN
the/DT
water/NN
and/CC
electrolyte/NN
balances/NNS
./.

High/JJ
affinity/NN
aldosterone/NN
binding/NN
sites/NNS
have/VBP
not/RB
only/RB
been/VBN
described/VBN
in/IN
the/DT
classic/JJ
target/NN
tissues/NNS
such/JJ
as/IN
the/DT
renal/JJ
tubules/NNS
,/,
but/CC
also/RB
in/IN
non-classic/JJ
target/NN
tissues/NNS
such/JJ
as/IN
the/DT
hippocampus/NN
,/,
mammary/JJ
gland/NN
,/,
endothelial/JJ
cells/NNS
and/CC
,/,
recently/RB
,/,
human/JJ
mononuclear/JJ
leukocytes/NNS
./.
=====
An/DT
in/FW
vitro/FW
effect/NN
of/IN
aldosterone/NN
on/IN
intracellular/JJ
sodium/NN
,/,
potassium/NN
and/CC
calcium/NN
concentrations/NNS
and/CC
cell/NN
volume/NN
was/VBD
shown/VBN
in/IN
human/JJ
mononuclear/JJ
leukocytes/NNS
./.
=====
In/IN
the/DT
absence/NN
of/IN
aldosterone/NN
,/,
the/DT
intracellular/JJ
Na+/NN
,/,
K+/NN
and/CC
Ca2+/NN
concentrations/NNS
and/CC
the/DT
cell/NN
volume/NN
decreased/VBD
significantly/RB
,/,
but/CC
remained/VBD
constant/JJ
when/WRB
aldosterone/NN
(/(
1.4/CD
nmol/l/NN
)/)
was/VBD
added/VBN
to/TO
the/DT
incubation/NN
medium/NN
./.
=====
These/DT
effects/NNS
of/IN
aldosterone/NN
were/VBD
blocked/VBN
by/IN
the/DT
aldosterone/NN
antagonist/NN
canrenone/NN
(/(
140/CD
nmol/l/NN
)/)
./.
=====
The/DT
sodium/proton/JJ
exchanger/NN
of/IN
the/DT
cell/NN
membrane/NN
could/MD
be/VB
identified/VBN
as/IN
the/DT
primary/JJ
target/NN
of/IN
the/DT
aldosterone/NN
action/NN
,/,
possibly/RB
non-genomically/RB
mediated/VBN
through/IN
membrane/NN
receptors/NNS
./.
=====
The/DT
clinical/JJ
significance/NN
of/IN
this/DT
model/NN
was/VBD
underlined/VBN
by/IN
the/DT
demonstration/NN
of/IN
absent/JJ
or/CC
a/DT
decreased/VBN
number/NN
of/IN
mineralocorticoid/NN
receptors/NNS
and/CC
the/DT
lack/NN
of/IN
electrolyte/NN
response/NN
to/TO
aldosterone/NN
in/IN
human/JJ
mononuclear/JJ
leukocytes/NNS
of/IN
patients/NNS
with/IN
pseudohypoaldosteronism/NN
and/CC
aldosteronism/NN
./.
=====
Additionally/RB
,/,
an/DT
abnormal/JJ
effector/NN
mechanism/NN
could/MD
be/VB
demonstrated/VBN
in/IN
human/JJ
mononuclear/JJ
leukocytes/NNS
from/IN
essential/JJ
hypertensives/NNS
./.
=====
These/DT
studies/NNS
are/VBP
the/DT
first/JJ
to/TO
demonstrate/VB
the/DT
significance/NN
of/IN
extrarenal/JJ
,/,
nonepithelial/JJ
mineralocorticoid/NN
receptors/NNS
and/CC
the/DT
related/JJ
effector/NN
mechanism/NN
in/IN
different/JJ
disorders/NNS
of/IN
the/DT
water/NN
and/CC
electrolyte/NN
balance/NN
in/IN
man/NN
./.